Association Between the Dialysate Bicarbonate and the Pre-dialysis Serum Bicarbonate Concentration in Maintenance Hemodialysis: A Retrospective Cohort Study.

IF 1.6 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Kidney Health and Disease Pub Date : 2024-05-30 eCollection Date: 2024-01-01 DOI:10.1177/20543581241256774
Amber O Molnar, Lauren Killin, Sarah Bota, Eric McArthur, Stephanie N Dixon, Amit X Garg, Claire Harris, Stephanie Thompson, Karthik Tennankore, Peter G Blake, Clara Bohm, Jennifer MacRae, Samuel A Silver
{"title":"Association Between the Dialysate Bicarbonate and the Pre-dialysis Serum Bicarbonate Concentration in Maintenance Hemodialysis: A Retrospective Cohort Study.","authors":"Amber O Molnar, Lauren Killin, Sarah Bota, Eric McArthur, Stephanie N Dixon, Amit X Garg, Claire Harris, Stephanie Thompson, Karthik Tennankore, Peter G Blake, Clara Bohm, Jennifer MacRae, Samuel A Silver","doi":"10.1177/20543581241256774","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is unclear whether the use of higher dialysate bicarbonate concentrations is associated with clinically relevant changes in the pre-dialysis serum bicarbonate concentration.</p><p><strong>Objective: </strong>The objective is to examine the association between the dialysate bicarbonate prescription and the pre-dialysis serum bicarbonate concentration.</p><p><strong>Design: </strong>This is a retrospective cohort study.</p><p><strong>Setting: </strong>The study was performed using linked administrative health care databases in Ontario, Canada.</p><p><strong>Patients: </strong>Prevalent adults receiving maintenance in-center hemodialysis as of April 1, 2020 (n = 5414) were included.</p><p><strong>Measurements: </strong>Patients were grouped into the following dialysate bicarbonate categories at the dialysis center-level: individualized (adjustment based on pre-dialysis serum bicarbonate concentration) or standardized (>90% of patients received the same dialysate bicarbonate concentration). The standardized category was stratified by concentration: 35, 36 to 37, and ≥38 mmol/L. The primary outcome was the mean outpatient pre-dialysis serum bicarbonate concentration at the patient level.</p><p><strong>Methods: </strong>We examined the association between dialysate bicarbonate category and pre-dialysis serum bicarbonate using an adjusted linear mixed model.</p><p><strong>Results: </strong>All dialysate bicarbonate categories had a mean pre-dialysis serum bicarbonate concentration within the normal range. In the individualized category, 91% achieved a pre-dialysis serum bicarbonate ≥22 mmol/L, compared to 87% in the standardized category. Patients in the standardized category tended to have a serum bicarbonate that was 0.25 (95% confidence interval [CI] = -0.93, 0.43) mmol/L lower than patients in the individualized category. Relative to patients in the 35 mmol/L category, patients in the 36 to 37 and ≥38 mmol/L categories tended to have a serum bicarbonate that was 0.70 (95% CI = -0.30, 1.70) mmol/L and 0.87 (95% CI = 0.14, 1.60) mmol/L higher, respectively. There was no effect modification by age, sex, or history of chronic lung disease.</p><p><strong>Limitations: </strong>We could not directly confirm that all laboratory measurements were pre-dialysis. Data on prescribed dialysate bicarbonate concentrations for individual dialysis sessions were not available, which may have led to some misclassification, and adherence to a practice of individualization could not be measured. Residual confounding is possible.</p><p><strong>Conclusions: </strong>We found no significant difference in the pre-dialysis serum bicarbonate concentration irrespective of whether an individualized or standardized dialysate bicarbonate was used. Dialysate bicarbonate concentrations ≥38 mmol/L (vs 35 mmol/L) may increase the pre-dialysis serum bicarbonate concentration by 0.9 mmol/L.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141227/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Kidney Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20543581241256774","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: It is unclear whether the use of higher dialysate bicarbonate concentrations is associated with clinically relevant changes in the pre-dialysis serum bicarbonate concentration.

Objective: The objective is to examine the association between the dialysate bicarbonate prescription and the pre-dialysis serum bicarbonate concentration.

Design: This is a retrospective cohort study.

Setting: The study was performed using linked administrative health care databases in Ontario, Canada.

Patients: Prevalent adults receiving maintenance in-center hemodialysis as of April 1, 2020 (n = 5414) were included.

Measurements: Patients were grouped into the following dialysate bicarbonate categories at the dialysis center-level: individualized (adjustment based on pre-dialysis serum bicarbonate concentration) or standardized (>90% of patients received the same dialysate bicarbonate concentration). The standardized category was stratified by concentration: 35, 36 to 37, and ≥38 mmol/L. The primary outcome was the mean outpatient pre-dialysis serum bicarbonate concentration at the patient level.

Methods: We examined the association between dialysate bicarbonate category and pre-dialysis serum bicarbonate using an adjusted linear mixed model.

Results: All dialysate bicarbonate categories had a mean pre-dialysis serum bicarbonate concentration within the normal range. In the individualized category, 91% achieved a pre-dialysis serum bicarbonate ≥22 mmol/L, compared to 87% in the standardized category. Patients in the standardized category tended to have a serum bicarbonate that was 0.25 (95% confidence interval [CI] = -0.93, 0.43) mmol/L lower than patients in the individualized category. Relative to patients in the 35 mmol/L category, patients in the 36 to 37 and ≥38 mmol/L categories tended to have a serum bicarbonate that was 0.70 (95% CI = -0.30, 1.70) mmol/L and 0.87 (95% CI = 0.14, 1.60) mmol/L higher, respectively. There was no effect modification by age, sex, or history of chronic lung disease.

Limitations: We could not directly confirm that all laboratory measurements were pre-dialysis. Data on prescribed dialysate bicarbonate concentrations for individual dialysis sessions were not available, which may have led to some misclassification, and adherence to a practice of individualization could not be measured. Residual confounding is possible.

Conclusions: We found no significant difference in the pre-dialysis serum bicarbonate concentration irrespective of whether an individualized or standardized dialysate bicarbonate was used. Dialysate bicarbonate concentrations ≥38 mmol/L (vs 35 mmol/L) may increase the pre-dialysis serum bicarbonate concentration by 0.9 mmol/L.

维持性血液透析中透析液碳酸氢盐与透析前血清碳酸氢盐浓度之间的关系:回顾性队列研究。
背景:目前尚不清楚使用较高浓度的透析液碳酸氢盐是否与透析前血清碳酸氢盐浓度的临床相关变化有关:目的:研究透析液碳酸氢盐处方与透析前血清碳酸氢盐浓度之间的关联:这是一项回顾性队列研究:研究利用加拿大安大略省的行政医疗数据库进行:纳入截至 2020 年 4 月 1 日接受中心内维持性血液透析的成年患者(n = 5414):在透析中心层面将患者分为以下透析液碳酸氢盐类别:个性化(根据透析前血清碳酸氢盐浓度进行调整)或标准化(大于 90% 的患者接受相同的透析液碳酸氢盐浓度)。标准化类别按浓度分层:35、36 至 37 和 ≥38 mmol/L。主要结果是门诊患者透析前血清碳酸氢盐的平均浓度:我们使用调整线性混合模型研究了透析液碳酸氢盐类别与透析前血清碳酸氢盐之间的关系:结果:所有透析液碳酸氢盐类别的透析前血清碳酸氢盐平均浓度均在正常范围内。在个体化类别中,91% 的患者透析前血清碳酸氢盐浓度≥22 mmol/L,而在标准化类别中,这一比例为 87%。标准化组患者的血清碳酸氢盐往往比个体化组患者低 0.25(95% 置信区间 [CI] = -0.93,0.43)毫摩尔/升。相对于 35 mmol/L 类别的患者,36 至 37 mmol/L 和 ≥38 mmol/L 类别患者的血清碳酸氢盐分别倾向于高出 0.70(95% 置信区间 [CI] = -0.30,1.70)mmol/L 和 0.87(95% 置信区间 [CI] = 0.14,1.60)mmol/L。年龄、性别或慢性肺部疾病史均不会对研究结果产生影响:我们无法直接确认所有实验室测量值均为透析前测量值。我们无法直接确认所有实验室测量值均为透析前的数据,也无法获得各透析疗程的透析液碳酸氢盐浓度数据,这可能会导致一些错误分类,同时也无法衡量是否坚持了个体化治疗。结论:我们发现,无论使用个体化还是标准化透析液碳酸氢盐,透析前血清碳酸氢盐浓度均无明显差异。透析液碳酸氢盐浓度≥38 mmol/L(vs 35 mmol/L)可能会使透析前血清碳酸氢盐浓度增加 0.9 mmol/L。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.90%
发文量
84
审稿时长
12 weeks
期刊介绍: Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation. Our mandate is to promote and advocate for kidney health as it impacts national and international communities. Basic science, translational studies and clinical studies will be peer reviewed and processed by an Editorial Board comprised of geographically diverse Canadian and international nephrologists, internists and allied health professionals; this Editorial Board is mandated to ensure highest quality publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信